Connect
MJA
MJA

Pharmaceutical preparations

Editorial

Cerebral palsy in Australia: optimism and challenges

Rod W Hunt

Med J Aust 2024; 221 (10): 529-530 Free

Ethics and law

Aligning legislation with clinical practice: off‐label prescribing under the microscope

Narcyz Ghinea

Med J Aust 2024; 221 (8): 417-419 Free

Research

Concurrent use of hormonal long‐acting reversible contraception by women of reproductive age dispensed teratogenic medications, Australia, 2013–2021: a retrospective cohort study

Luke E Grzeskowiak, Vivienne Moore, Kelly Hall, Jenni Ilomäki, Danielle Schoenaker, Elizabeth Lovegrove, Danielle Mazza, Kirsten I Black, Debra S Kennedy, Michael J Davies and Alice Rumbold

Med J Aust 2024; 221 (7): 367-373 Free

Perspective

Cost barriers to medication access in Australia: an analysis of the Patient Experience Survey in context

Narcyz Ghinea

Med J Aust 2024; 221 (8): 414-416 Free

Perspective

Pharmaceuticals in pregnancy: a multifaceted challenge in Australia

Stefan C Kane, Renuka Shanmugalingam and Amanda Henry

Med J Aust 2024; 221 (7): 357-359 Free

Medical education / Lessons from practice

Smouldering COVID‐19 XBB.1.5. subvariant pneumonitis: a case report

Sara Davison, Tanmay Kanitkar, Dimitrios Menouhos, Thomas Ewin, Catherine S Marshall, Peter Boan and Sonja Janson

Med J Aust 2024; 221 (5): 244-245 Free

Letter to the editor

Hidden danger: maize starch excipient allergy

Wala Hamid Haj Ali, Corey Borg and Catherine Leggett

Med J Aust 2024; 221 (5): 285-286 Free

Perspective

Calling time on the use of modified‐release opioids for acute pain

Pamela E Macintyre, Melissa A Jamcotchian and Jennifer A Stevens

Med J Aust 2024; 221 (6): 293-296 Free

Medical education / Key research skills

Understanding modelled economic evaluations: a reader's guide for clinicians

Winnie Chen, Martin Howell, Alan Cass, Gillian Gorham and Kirsten Howard

Med J Aust 2024; 221 (6): 302-307 Free

Editorial

The resurgence of congenital syphilis in Australia: novel approaches and sustained, effective public health efforts are required

Stephanie Bond and Marcus Y Chen

Med J Aust 2024; 221 (4): 195-196 Free

Editorial

Ensuring a fit‐for‐purpose resource for consumers, clinicians and health services: the updated Osteoarthritis of the Knee Clinical Care Standard

Ilana N Ackerman, Fiona Doukas, Rachelle Buchbinder, Sally Dooley, Wendy Favorito, Phoebe Holdenson Kimura, David J Hunter, James Linklater, John B North, Louise Elvin‐Walsh, Christopher Vertullo, Alice L Bhasale and Samantha Bunzli

Med J Aust 2024; 221 (4): 197-200 Free

Medical education / Lessons from practice

Treatment‐resistant tinea caused by Trichophyton indotineae in Australia

Kyra YL Chua, Catriona L Halliday, Sharon C‐A Chen, Sonia Koning, Jedrzej Pawlikowski, Philipp du Cros and Tony M Korman

Med J Aust 2024; 221 (4): 192-194 Free

Perspective

National pharmacovigilance of seasonal influenza vaccines in Australia

Megan O'Moore, Belinda Jones, Megan Hickie, Catherine Glover, Lucy Deng, Yuanfei Huang, Michael Dymock, Evelyn Tay, Julie A Marsh and Nicholas Wood

Med J Aust 2024; 221 (4): 178-181 Free

Letters

Is the current commercial model of medicinal cannabis in the best interest of patients?

Richard CJ Bradlow and Ferghal Armstrong

Med J Aust 2024; 220 (11): 592-592 Free

Perspectives

Ethics of artificial intelligence in supportive care in cancer

Ian N Olver

Med J Aust 2024; 220 (10): 499-501 Free

Research letter

Pharmaceutical company payments to Australian doctors reported to Medicines Australia, 2019–22: a cross‐sectional analysis

Malcolm Forbes, Yeshna Bhowon and Barbara Mintzes

Med J Aust 2024; 220 (8): 425-427 Free

Medical education / Lessons from practice

Measurement of digoxin levels falsely affected by enzalutamide

Noor Lammoza, Maria Hormiz, Cherie Chiang, Chris Stead, Mustafa Ayhan and Samuel C Hume

Med J Aust 2024; 220 (9): 455-456 Free

Editorials

Interventions for reducing the prescribing of pharmaceutical opioids in Australia: are they effectively reducing opioid harm?

Suzanne Nielsen and Ting Xia

Med J Aust 2024; 220 (6): 311-312

Research

The impact of tightened prescribing restrictions for PBS-subsidised opioid medicines and the introduction of half-pack sizes, Australia, 2020–21: an interrupted time series analysis

Forrest C Koch, Jake Olivier, Jonathan Brett, Nicholas A Buckley, Natasa Gisev, Sallie Pearson and Benjamin Daniels

Med J Aust 2024; 220 (6): 315-322 Free

Research letters

The uptake of long‐acting depot buprenorphine for treating opioid dependence in Australia, 2019–2022: longitudinal sales data analysis

Nicholas Lintzeris, Victoria Hayes and Adrian J Dunlop

Med J Aust 2024; 220 (6): 339-340 Free

Medical education / Lessons from practice

Hidden danger: maize starch excipient allergy

Lipin Lukose, Shrey Seth, Kamal Sud, Brian Nankivell, Mary Ann Nicdao and Ronald L Castelino

Med J Aust 2024; 220 (4): 184-185 Free

Editorial

Antibiotics or watchful waiting for acute otitis media in urban Aboriginal and Torres Strait Islander children?

Valerie M Swift and Christopher G Brennan‐Jones

Med J Aust 2024; 220 (4): 186-187 Free

Research

The views of parents and carers on managing acute otitis media in urban Aboriginal and Torres Strait Islander children: a qualitative study

Jennifer S Reath, Sarah O'Brien, Letitia Campbell, Hasantha Gunasekera, Claudette A Tyson, Deborah A Askew, Wendy Hu, Tim Usherwood, Kelvin Kong, Peter Morris, Amanda J Leach, Robyn Walsh and Penelope A Abbott

Med J Aust 2024; 220 (4): 202-207 Free

Perspectives

Inflammation: the next target for secondary prevention in coronary artery disease

Samia Kazi, James J H Chong and Clara K Chow

Med J Aust 2024; 220 (3): 115-120 Free

Letters

Proposals to waive intellectual property rights for pandemic response products in the World Health Organization pandemic accord need Australia's support

Thomas Cueni and Elizabeth Somer

Med J Aust 2023; 219 (9): 439-439 Free